HTAi Policy Forum Members
For-profit organizations
- Abbott Vascular International BVBA
- AstraZeneca Plc
- Bayer Healthcare/Bayer Pharma Schering
- Bristol-Myers Squibb
- Covidien
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline
- Johnson & Johnson Medical Products
- Medtronic
- Merck & Co
- Merck Serono International SA
- Novartis Pharma AG
- Pfizer Limited
- Sanofi-Aventis
Not-for-profit organizations
- AHRQ - Agency for Healthcare Research & Quality, Center for Outcomes and Evidence (USA)
- MSAC - Australian Government, Department of Health & Ageing
- PBAC - Australian Government, Department of Health & Ageing
- BlueCrossBlueShield Association
- CADTH - Canadian Agency for Drugs and Technologies in Health
- CVZ - Dutch health care insurance board
- ICER - Institute for Clinical & Economic Review (USA)
- Kaiser Permanente
- NICE - National Institute for Health and Clinical Excellence (UK)
- NOKC - Norwegian Knowledge Centre for the Health Services
- CMTP - Center for Medical Technology Policy (USA)
- AIFA - Italian Medicines Agency
- Swedish Council on HTA (SBU) and Swedish Dental and Pharmaceutical Benefits Agency (TLV) - joint membership
This page was last updated on:
25 February 2013
25 February 2013
